Sleep Disorders Trial, Recruiting NCT07101796 Sponsor: Peking University First Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07101796
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 18 and 70 years old
  • People who have symptoms that suggest sleep apnoea (such as snoring, waking during the night, or feeling sleepy during the day), people who need sleep apnoea screening because of a related health condition, or people who have already been diagnosed with sleep apnoea and have been referred for sleep monitoring or CPAP pressure testing
  • People who are fully alert and able to think and act independently, including being able to answer questions on their own
  • People who have agreed to take part in the study and are willing to cooperate with the related assessments and treatment

Who may not be able to join:

  • People who are younger than 18 or older than 70 years old
  • People who have no symptoms of sleep apnoea, do not need sleep apnoea screening, or have not been diagnosed with sleep apnoea
  • People who are not fully independent in their thinking or daily actions, or who are unable to answer questions on their own
  • People who have not given their agreement to participate, or who are unwilling to cooperate with the study's treatment and assessments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jing Ma, Peking University First Hospital

Phone: 8613651357974

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University First Hospital
Registry
ClinicalTrials.gov
Start date
14 September 2024
Est. completion
1 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Eysenck Personality Questionnaire (EPQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov